EUVIMEDEUVIMED entdecken
Vergleichsstudie

Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure

Tak Kyu Oh iD, In-Ae Song iD

Perfusion · 2025

DOI: 10.1177/02676591241281792 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Perfusion, 2025. Verfasst von Tak Kyu Oh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Respiratory Distress Syndrome, Respiratory Insufficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Extracorporeal membrane oxygenation (ECMO) is a vital intervention for acute respiratory distress syndrome (ARDS), yet its efficacy with coronavirus disease 2019 (COVID-19) remains unknown. This study compared the long-term mortality rates of patients receiving ECMO for COVID-19 with those experiencing other respiratory disease-associated ARDS.

Methods

This retrospective cohort study included adults with ARDS receiving ECMO for respiratory disease (COVID-19 and non-COVID-19) based on information collected from the National Health Insurance Service of South Korea from February 1, 2020, to December 31, 2021. The primary outcome was all-cause mortality at 6 months and 1 year post-ECMO initiation.

Results

Data from 3094 patients with COVID-19 ( N = 1095) and non-COVID-19 respiratory disease-associated ARDS ( N = 1999) who received ECMO support were analyzed. Despite a higher Charlson Comorbidity index in the non-COVID group, patients with COVID-19 had higher cumulative mortality rates at 6 months and 1 year post-ECMO initiation compared to those with non-COVID-19 respiratory diseases, after adjusting for confounders. Patients with COVID-19 also experienced longer intensive care unit stays, higher hospitalization costs, longer ECMO and mechanical ventilation durations, and lower intensity coverage.

Conclusions

Patients with COVID-19 requiring ECMO showed higher mortality rates, possibly due to its distinct long-lasting and potentially fatal consequences compared to other respiratory illnesses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationCOVID-19Respiratory Distress SyndromeRespiratory InsufficiencyHumansMaleFemaleRetrospective StudiesMiddle AgedAdultSARS-CoV-2AgedRepublic of Korea

Stichwörter der Autor:innen

COVID-19acute respiratory distress syndromecritical careextracorporeal membrane oxygenationintensive care unitsmortality

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Department of Anesthesiology and Pain Medicine, College of Medicine, Seoul National University, Seoul, South Korea.

ORCID-Profile: Tak Kyu Oh, In-Ae Song

Zitieren

APA

Oh, T. K., & Song, I. A. (2025). Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure. Perfusion. https://doi.org/10.1177/02676591241281792

Vancouver

Oh TK, Song IA. Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure. Perfusion. 2025. doi:10.1177/02676591241281792

BibTeX
@article{Oh2025,
  author = {Oh, Tak Kyu and Song, In-Ae},
  title = {Extracorporeal membrane oxygenation support in adult patients: Comparing COVID-19- and non-COVID-19-associated respiratory failure},
  journal = {Perfusion},
  year = {2025},
  doi = {10.1177/02676591241281792}
}
Kostenlos starten →